rss
Ann Rheum Dis doi:10.1136/ard.2007.082339

Anti-CCP revised criteria for the classification of rheumatoid arthritis

  1. Katherine P Liao (kliao{at}partners.org)
  1. Brigham and Women's Hospital, United States
    1. Kerri L Batra (kbatra{at}partners.org)
    1. Brigham and Women's Hospital, United States
      1. Lori Chibnik (lchibnik{at}rics.bwh.harvard.edu)
      1. Brigham and Women's Hospital, United States
        1. Peter H Schur (pschur{at}partners.org)
        1. Brigham & Women's Hospital-Harvard Med School, United States
          1. Karen H Costenbader (kcostenbader{at}partners.org)
          1. Brigham and Women's Hospital; Assistant Professor of Medicine, Harvard Medical School, United States
            • Published Online First 30 January 2008

            Abstract

            Objective: Classification of rheumatoid arthritis (RA) is increasingly important as new therapies can halt the disease in its early stages. Antibodies to cyclic citrullinated peptides (anti-CCP) are widely used for RA diagnosis, but are not in the 1987 American College of Rheumatology (ACR) Criteria for RA Classification. We developed and tested the performance characteristics of new criteria for RA classification, incorporating anti-CCP.

            Methods: We identified all subjects seen in our Arthritis Center with rheumatoid factor (RF) and anti-CCP tested simultaneously between January 1 and June 30, 2004 and reviewed their medical records for the ACR criteria, rheumatologists’ diagnoses, RF and anti-CCP. We revised the ACR criteria in two ways: (1) adding anti-CCP, (2) replacing rheumatoid nodules and erosions with anti-CCP (CCP 6 criteria). We compared sensitivity and specificity of all criteria, in all subjects and in subjects with arthritis symptoms < 6 months.

            Results: Medical records of 292 subjects were analysed: mean age was 54 years, 82% were women, and mean symptom duration was 4.1 years. 17% were RF+ and 14% were anti-CCP+ at initial testing. 78 (27%) had definite RA per treating rheumatologist at latest follow-up.

            The CCP 6 criteria increased sensitivity for RA classification for all subjects regardless of symptom duration: 74% vs. 51% for ACR criteria with a loss in specificity (81% vs. 91%). Sensitivity was greatly improved in subjects with symptoms < 6 months: 25% vs. 63% for ACR criteria with a decrease in specificity.

            Conclusion: The CCP 6 criteria improved upon the sensitivity of the ACR criteria, most remarkably for subjects with symptoms < 6 months and could be used for classification of subjects for RA in clinical studies.

            This Article

            1. Abstract
            2. PDF
            3. All versions of this article:
              1. ard.2007.082339v1
              2. 67/11/1557most recent

            Responses

            1. Submit a response
            2. No responses published

            Register for free content

            The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

            Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.